Novel Aptamers Selected on Living Cells for Specific Recognition of Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is a high heterogeneous group of tumors with a distinctly aggressive nature and high rates of relapse. So far, the lack of any known targetable proteins has not allowed a specific anti-tumor treatment. Therefore, the identification of novel agents for specific TN...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:iScience
Autors principals: Camorani, Simona, Granata, Ilaria, Collina, Francesca, Leonetti, Francesco, Cantile, Monica, Botti, Gerardo, Fedele, Monica, Guarracino, Mario Rosario, Cerchia, Laura
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2020
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7103779/
https://ncbi.nlm.nih.gov/pubmed/32222697
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.isci.2020.100979
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars